Beone Medicines Ltd (06160) has announced a new equity incentive grant. On August 7, 2026, the Compensation Committee of the Board approved the award of 40,764 restricted stock units (RSUs) representing American Depositary Shares to 362 grantees.

These RSUs are equivalent to 529,932 ordinary shares of the company. This figure represents approximately 0.03% of the total issued shares of the company as of the date of this announcement. The awards were granted under the terms of the 2016 Share Option and Incentive Plan.